Literature DB >> 24266677

Identification of Maillard reaction products on peanut allergens that influence binding to the receptor for advanced glycation end products.

G A Mueller1, S J Maleki, K Johnson, B K Hurlburt, H Cheng, S Ruan, J B Nesbit, A Pomés, L L Edwards, A Schorzman, L J Deterding, H Park, K B Tomer, R E London, J G Williams.   

Abstract

BACKGROUND: Recent immunological data demonstrated that dendritic cells preferentially recognize advanced glycation end product (AGE)-modified proteins, upregulate expression of the receptor for AGE (RAGE), and consequently bias the immune response toward allergy.
METHODS: Peanut extract was characterized by mass spectrometry (MS) to elucidate the specific residues and specific AGE modifications found in raw and roasted peanuts and on rAra h 1 that was artificially glycated by incubation with glucose or xylose. The binding of the RAGE-V1C1 domain to peanut allergens was assessed by PAGE and Western analysis with anti-Ara h 1, 2, and 3 antibodies. IgE binding to rAra h 1 was also assessed using the same methods.
RESULTS: AGE modifications were found on Ara h 1 and Ara h 3 in both raw and roasted peanut extract. No AGE modifications were found on Ara h 2. Mass spectrometry and Western blot analysis demonstrated that RAGE binds selectively to Ara h 1 and Ara h 3 derived from peanut extract, whereas the analysis failed to demonstrate Ara h 2 binding to RAGE. rAra h 1 with no AGE modifications did not bind RAGE; however, after AGE modification with xylose, rAra h 1 bound to RAGE.
CONCLUSIONS: AGE modifications to Ara h 1 and Ara h 3 can be found in both raw and roasted peanuts. Receptor for AGE was demonstrated to selectively interact with AGE-modified rAra h 1. If sensitization to peanut allergens occurs in dendritic cells via RAGE interactions, these cells are likely interacting with modified Ara h 1 and Ara h 3, but not Ara h 2.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Entities:  

Keywords:  advanced glycation end product; allergens; epitopes; peanuts; receptor for AGE

Mesh:

Substances:

Year:  2013        PMID: 24266677      PMCID: PMC3915869          DOI: 10.1111/all.12261

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  23 in total

1.  The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy.

Authors:  Marjolein Wensing; André H Penninks; Susan L Hefle; Stef J Koppelman; Carla A F M Bruijnzeel-Koomen; André C Knulst
Journal:  J Allergy Clin Immunol       Date:  2002-12       Impact factor: 10.793

Review 2.  Posttranslational modifications of self-antigens.

Authors:  Hester A Doyle; Mark J Mamula
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

3.  Nitration enhances the allergenic potential of proteins.

Authors:  Y K Gruijthuijsen; I Grieshuber; A Stöcklinger; U Tischler; T Fehrenbach; M G Weller; L Vogel; S Vieths; U Pöschl; A Duschl
Journal:  Int Arch Allergy Immunol       Date:  2006-08-23       Impact factor: 2.749

4.  Association of end-product adducts with increased IgE binding of roasted peanuts.

Authors:  S Y Chung; E T Champagne
Journal:  J Agric Food Chem       Date:  2001-08       Impact factor: 5.279

Review 5.  Current developments in peanut allergy.

Authors:  Kricia Palmer; Wesley Burks
Journal:  Curr Opin Allergy Clin Immunol       Date:  2006-06

6.  RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells.

Authors:  H Zill; R Günther; H F Erbersdobler; U R Fölsch; V Faist
Journal:  Biochem Biophys Res Commun       Date:  2001-11-16       Impact factor: 3.575

7.  The effects of roasting on the allergenic properties of peanut proteins.

Authors:  S J Maleki; S Y Chung; E T Champagne; J P Raufman
Journal:  J Allergy Clin Immunol       Date:  2000-10       Impact factor: 10.793

8.  Global proteomic screening of protein allergens and advanced glycation endproducts in thermally processed peanuts.

Authors:  Christine M Hebling; Melinda A McFarland; John H Callahan; Mark M Ross
Journal:  J Agric Food Chem       Date:  2012-10-16       Impact factor: 5.279

9.  Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study.

Authors:  Scott H Sicherer; Anne Muñoz-Furlong; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2003-12       Impact factor: 10.793

10.  Effect of Maillard reaction on biochemical properties of peanut 7S globulin (Ara h 1) and its interaction with a human colon cancer cell line (Caco-2).

Authors:  Małgorzata Teodorowicz; Ewa Fiedorowicz; Henryk Kostyra; Harry Wichers; Elżbieta Kostyra
Journal:  Eur J Nutr       Date:  2013-01-20       Impact factor: 5.614

View more
  17 in total

1.  The molecular basis of peanut allergy.

Authors:  Geoffrey A Mueller; Soheila J Maleki; Lars C Pedersen
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

2.  Glycoproteomic analysis of seven major allergenic proteins reveals novel post-translational modifications.

Authors:  Adnan Halim; Michael C Carlsson; Caroline Benedicte Madsen; Stephanie Brand; Svenning Rune Møller; Carl Erik Olsen; Sergey Y Vakhrushev; Jens Brimnes; Peter Adler Wurtzen; Henrik Ipsen; Bent L Petersen; Hans H Wandall
Journal:  Mol Cell Proteomics       Date:  2014-11-11       Impact factor: 5.911

3.  Enhanced Approaches for Identifying Amadori Products: Application to Peanut Allergens.

Authors:  Katina L Johnson; Jason G Williams; Soheila J Maleki; Barry K Hurlburt; Robert E London; Geoffrey A Mueller
Journal:  J Agric Food Chem       Date:  2016-02-05       Impact factor: 5.279

4.  Dry roasting enhances peanut-induced allergic sensitization across mucosal and cutaneous routes in mice.

Authors:  Amin E Moghaddam; William R Hillson; Mario Noti; Kate H Gartlan; Steven Johnson; Benjamin Thomas; David Artis; Quentin J Sattentau
Journal:  J Allergy Clin Immunol       Date:  2014-09-22       Impact factor: 10.793

5.  Human monocyte-derived type 1 and 2 macrophages recognize Ara h 1, a major peanut allergen, by different mechanisms.

Authors:  Maren Krause; Peter Crauwels; Frank Blanco-Pérez; Martin Globisch; Andrea Wangorsch; Thomas Henle; Jonas Lidholm; Ger van Zandbergen; Stefan Vieths; Stephan Scheurer; Masako Toda
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

6.  Modeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance for early neuropathological processes.

Authors:  Iris N Serratos; Pilar Castellanos; Nina Pastor; César Millán-Pacheco; Daniel Rembao; Ruy Pérez-Montfort; Nallely Cabrera; Francisco Reyes-Espinosa; Paulina Díaz-Garrido; Ambar López-Macay; Karina Martínez-Flores; Alberto López-Reyes; Aurora Sánchez-García; Elvis Cuevas; Abel Santamaria
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

7.  Purification of Recombinant Peanut Allergen Ara h 1 and Comparison of IgE Binding to the Natural Protein.

Authors:  Barry K Hurlburt; Jane K McBride; Jacqueline B Nesbit; Sanbao Ruan; Soheila J Maleki
Journal:  Foods       Date:  2014-12-18

8.  Comparison of the Digestibility of the Major Peanut Allergens in Thermally Processed Peanuts and in Pure Form.

Authors:  Soheila J Maleki; David A Schmitt; Maria Galeano; Barry K Hurlburt
Journal:  Foods       Date:  2014-05-07

9.  In vitro evaluation of digestive and endolysosomal enzymes to cleave CML-modified Ara h 1 peptides.

Authors:  Christopher P Mattison; Jens Dinter; Matthew J Berberich; Si-Yin Chung; Shawndrika S Reed; Sylvie Le Gall; Casey C Grimm
Journal:  Food Sci Nutr       Date:  2015-03-12       Impact factor: 2.863

10.  Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice.

Authors:  James A Gregory; Ariel Shepley-McTaggart; Michelle Umpierrez; Barry K Hurlburt; Soheila J Maleki; Hugh A Sampson; Stephen P Mayfield; M Cecilia Berin
Journal:  Plant Biotechnol J       Date:  2016-01-23       Impact factor: 9.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.